NeuroEquilibrium, a pioneering medical technology startup specializing in dizziness, vertigo, and balance disorders, has appointed industry veteran Samit Verma as its Chief Executive Officer.

Samit brings a wealth of experience from his previous role as Managing Director at Amplifon India, a subsidiary of the global hearing care industry leader, Amplifon S.p.A.

During his 12-year tenure at Amplifon, Samit played a pivotal role in establishing and expanding the business, overseeing its growth to encompass over 250 point-of-sales. His appointment as CEO at NeuroEquilibrium aligns with the company's strategic vision for domestic and global expansion, supported by key investors such as Kotak Ventures, Unicorn India Ventures, and RVCF Ventures.

Commenting on the development, NeuroEquilibrium Founder Rajneesh Bhandari expressed enthusiasm for the company's growth phase and welcomed Samit Verma to the NeuroEquilibrium family. Dr. Anita Bhandari, co-founder and renowned neurotologist, expressed confidence in Samit's leadership, emphasizing the alignment of values and ethics.

Samit Verma, the newly appointed CEO, expressed excitement about leading NeuroEquilibrium, describing it as a cutting-edge medical technology startup. He highlighted the company's focus on addressing dizziness, vertigo, and balance disorders and expressed his commitment to contributing to NeuroEquilibrium's growth and its mission of delivering excellent clinical care globally.

With Samit Verma at the helm, NeuroEquilibrium aims to further solidify its position as a global leader in medical technology, leveraging its deep-tech proprietary platform powered by AI and providing best-in-class clinical excellence for patients and partners worldwide.